Literature DB >> 6723839

The single-breath N2-test and spirometry in healthy non-smoking males.

R Sixt, B Bake, H Oxhöj.   

Abstract

Healthy males (aged 30-70), who had never smoked, were studied. The 178 subjects were selected by systematic sampling from an urban population. Using the single-breath N2-washout test we measured the closing volume (CV) and the slope of the alveolar plateau (delta N2). A prediction equation for CV was produced by simple regression on age. delta N2 showed an accelerated increase with age above the age of 50. A curvilinear equation was established: delta N2 (%/1) = 0.85 + e0.0929 x A( yrs ) -6.302. Reference equations were also established for vital capacity (VC), forced expiratory volume in one second (FEV1) and FEV1 in per cent VC (FEV%) by means of linear multiple regression on age and height. The distribution of delta N2 was not homogenous throughout the age-range. As an upper limit of the reference range, we suggest 180% of the predicted value.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723839

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  4 in total

1.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

2.  Exercise performance after surgery for pulmonary atresia and intact ventricular septum.

Authors:  Britt-Marie Ekman-Joelsson; Per M Gustafsson; Jan Sunnegårdh
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

3.  Prediction of BOS by the single-breath nitrogen test in double lung transplant recipients.

Authors:  Gerdt C Riise; Gunnar Mårtensson; Birgitta Houltz; Björn Bake
Journal:  BMC Res Notes       Date:  2011-11-26

4.  Respiratory symptoms and peripheral airways disease in a cross-sectional study on a random population sample.

Authors:  Jan Yngve Olofson; Birgitta Houltz; Maria Nilsson Tengelin; Björn Bake
Journal:  BMJ Open       Date:  2012-11-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.